Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-Enriched Fat Grafting for Facial Pigmentation
NCT03564808Phase 2Unknown
- Sponsor
- King Edward Medical University
- Start
- Jun 2018
- Primary completion
- May 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of mesenchymal stem cells in craniofacial anomalies (CFA), Hyperpigmentation and Parry-Romberg syndrome (PRS) (2 arms), sponsored by King Edward Medical University. Primary endpoint: Pigmentary change at 6 months. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
craniofacial anomalies (CFA)HyperpigmentationParry-Romberg syndrome (PRS)
Beyond the preview
Go deeper on NCT03564808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03564808.